Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

799.08
+4.890.62%
Post-market: 800.231.15+0.14%19:30 EDT
Volume:894.27K
Turnover:713.29M
Market Cap:82.27B
PE:19.76
High:802.78
Open:782.44
Low:779.08
Close:794.19
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.48
T/O Rate:0.90%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.59
PE(LYR):19.26

Loading ...

BUZZ-CytomX rises on expanded Regeneron deal with up to $4 billion in milestones

Reuters
·
Jun 03

CytomX expands Regeneron bispecific cancer therapy collaboration, receives $37 million payment

Reuters
·
Jun 03

CytomX Therapeutics - Regeneron Secures Option for 6 Additional Targets; Total Milestones up to About $4 Bln

THOMSON REUTERS
·
Jun 03

CytomX Therapeutics - Eligible for Tiered Global Net Sales Royalties Under Collaboration

THOMSON REUTERS
·
Jun 03

Regeneron’s CLIO-1 Update: What a Completed Early Lymphoma Trial Means for REGN Investors

TIPRANKS
·
Jun 03

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), Vera Therapeutics (VERA) and Regeneron (REGN)

TIPRANKS
·
Jun 02

Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

FACTBOX-What Bundibugyo Ebola vaccines and treatments are under development

Reuters
·
Jun 01

WHO Ebola Trial Puts Regeneron’s Maftivimab Platform In Investor Focus

Simply Wall St.
·
May 31

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 30

Regeneron Advances Phase 3 ROXI-CAT-II Trial, Targeting Safer Cancer-Related Clot Treatment

TIPRANKS
·
May 30

FACTBOX-What Bundibugyo Ebola vaccines and treatments are under development

Reuters
·
May 29

Regeneron Treatment for Ebola Recommended for Priority Evaluation by WHO

Dow Jones
·
May 29

Regeneron Ebola antibody recommended by WHO for investigational use

TIPRANKS
·
May 29

Regeneron Pharmaceuticals Inc: Maftivimab Shown Broad Activity in Vitro Against Multiple Ebola Species, Including Bundibugyo

THOMSON REUTERS
·
May 29

Regeneron Pharmaceuticals Inc - Supply of Inmazeb Is Already on Ground in Drc

THOMSON REUTERS
·
May 29

Regeneron Pharmaceuticals - Preparing Maftivimab Supply for Clinical Trials; Inmazeb Available in Drc

THOMSON REUTERS
·
May 29

Regeneron Pharmaceuticals Inc: Maftivimab Has Been Recommended to Be Studied as a Monotherapy in Current Outbreak

THOMSON REUTERS
·
May 29

Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

THOMSON REUTERS
·
May 29

WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak

Reuters
·
May 29